Desvenlafaxine for the Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen: a Randomized, Double-blind, Placebo-controlled Study

Trial Profile

Desvenlafaxine for the Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen: a Randomized, Double-blind, Placebo-controlled Study

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Hot flashes; Vasomotor symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2017 Planned initiation date changed from 1 May 2017 to 1 Jul 2017.
    • 10 Jun 2017 Biomarkers information updated
    • 26 Apr 2017 Planned initiation date changed from 1 Sep 2016 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top